HEAD OF VALUE, EVIDENCE & ACCESS (JAPAN)

HEAD OF VALUE EVIDENCE AND ACCESS (JAPAN) Location.
Tokyo, Japan At Johnson & Johnson, we believe health is everything.
Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal.
Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https://www.
nj.
om/.
At the Johnson & Johnson Innovative Medicine, guided by "Our Credo ", what matters most is helping people live full and healthy lives.
We focus on treating, curing and preventing some of the most devastating and complex diseases of our time.
And we pursue the most promising science, wherever it might be found.
Johnson & Johnson Innovative Medicine discovers and develops innovative medical solutions to address important unmet medical needs in oncology, immunology, neuroscience and cardiovascular and metabolic diseases.
The Head of Value Evidence & Access (VEA) is a key strategic position in IMAT (Integrated Market Access Team) and J&J Innovative Medicines Japan to drive HTA preparation, submission and negotiation, as well as evidence generation to meet access needs.
In the evolving healthcare environment in Japan, this position will work with other department heads in IMAT (Pricing, Policy) to design for access and strengthen the market access capability within the organization.
The Head of VE&A will also work closely with other functions in Janssen Japan including NPP, MAF, R&D and Commercial, as well as regional and global leaders.
The main responsibilities are.
Lead the team to assess likelihood of HTA designation during LRFP and other decision-making process.
Drive strategy of HTA preparation, submission and negotiation.
Participate in IMAT Leadership reviews for key access decisions.
Build overall Market Access evidence generation strategy for Janssen Japan, which should be aligned with local company’s and regional/global market access strategy.
Work closely with regional / global market access team to communicate Japan’s access evidence needs.
Work closely with cross functional teams to develop and strengthen company’s market access and evidence generation capability.
Develop and maintain strategic relationships with key external stakeholders, e.
.
Industry associations, Academia key opinion leaders; Support external engagement on HTA related policy strategy in collaboration with the policy department.
Manage budget and support team members’ development.
Qualifications As the Head of VEA, you will have.
Minimum 8 years of experience in health economics or market access in healthcare industry is required.
In-depth understanding of governments and their perspective on Healthcare/Social insurance strategy is required.
Knowledge on health economic analysis and methodology used in evidence generation.
Experience in building teams and managing people and budgets.
Demonstrable success in a complex matrix environment It is essential that you come with.
Strong collaboration/communication skills.
Ability to drive and shape the decision-making.
Clear prioritization.
Ability to understand both science and business strategy; Identify solutions to support the company’s business goals.
Adaptability to the local culture and way of working.
Business English skill is required; Japanese is preferred.
Education requirement.
Higher degree in related fields such as Pharmacy, Health Economics, Outcomes Research, Health Services Research, Public Health, and Epidemiology is preferred.